Holen Sie sich die Stockscreener-App
100.04
2.01%
-2.05
Vorhandelsmarkt:
100.04
Schlusskurs vom Vortag:
$102.09
Offen:
$101.46
24-Stunden-Volumen:
8.56M
Relative Volume:
1.04
Marktkapitalisierung:
$154.11B
Einnahmen:
$17.55B
Nettoeinkommen (Verlust:
$2.03B
KGV:
73.02
EPS:
1.37
Netto-Cashflow:
$2.72B
1W Leistung:
-3.96%
1M Leistung:
-2.74%
6M Leistung:
+12.76%
1J Leistung:
+29.74%
1-Tages-Spanne:
$99.62
$101.54
1-Wochen-Bereich:
$99.62
$105.78
52-Wochen-Spanne:
$71.88
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
100.04 | 154.11B | 17.55B | 2.03B | 2.72B | 1.37 |
|
ABT
Abbott Laboratories
|
133.40 | 232.39B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
382.28 | 145.55B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.45 | 107.35B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.36 | 45.81B | 5.54B | 4.18B | 623.10M | 7.00 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks? - MSN
Boston Scientific lists 24-acre Minnetonka campus for sale ahead of Maple Grove move - The Business Journals
Boston Scientific (BSX) Upgraded to Buy: Here's Why - Nasdaq
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? - Nasdaq
Boston Scientific’s EVP sells $5.8 million in stock By Investing.com - Investing.com Nigeria
Boston Scientific’s EVP sells $5.8 million in stock - Investing.com
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Boston Scientific (NYSE:BSX) Secures US$30-45 Million Deal with Bittium for ECG Devices - Yahoo Finance
Emerging Markets Power Boston Scientific: Will The Growth Trend Continue? - Barchart.com
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Emerging Markets Power Boston Scientific: Will the Growth Trend Continue? - Yahoo Finance
How Is Boston Scientific's Stock Performance Compared To Other Medical Device Stocks? - Barchart.com
Rising obesity levels spur endoscopic sleeve uptick - BioWorld MedTech
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
Boston Scientific’s longtime DEI, HR leader exits for chief HR role at new company - MassDevice
Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scienti - GuruFocus
Before the Bell-Boston Scientific drops on profit miss - Reuters
Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scientific Corp (BSX) - GuruFocus
Piper Sandler maintains Boston Scientific stock at Overweight - Investing.com
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand | The Insight Partners - GlobeNewswire Inc.
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook - Benzinga
Boston Scientific ends TAVR sales; J&J shares Monarch robot data - MedTech Dive
Boston Scientific (BSX) Ends Acurate TAVR Program, Shifts Focus to Promising Projects | BSX Stock News - GuruFocus
BSX: Analyst Reiterates Buy Rating for Boston Scientific | BSX S - GuruFocus
In TAVR setback, Boston Sci pulls plug on Acurate valves - BioWorld MedTech
Boston Scientific discontinues Acurate TAVR sales, cites regulatory burden - MassDevice
Boston Scientific Ends ACURATE Valve Sales By Investing.com - Investing.com Canada
Evercore ISI maintains Boston Scientific stock at Outperform - Investing.com
TD Cowen maintains Boston Scientific stock at $115 target By Investing.com - Investing.com South Africa
TD Cowen maintains Boston Scientific stock at $115 target - Investing.com
Boston Scientific (BSX) Discontinues Sales of ACURATE Aortic Valve Systems - GuruFocus
Boston Scientific (BSX) Discontinues Valve Product Amid Regulato - GuruFocus
JPMorgan maintains Boston Scientific stock with $135 target - Investing.com
Citi maintains Buy on Boston Scientific, keeps $125 target - Investing.com
Needham sees Boston Scientific stock as a buy, target at $115 - Investing.com
Boston Scientific (BSX) Discontinues Valve Product Amid Regulatory Challenges | BSX Stock News - GuruFocus
Boston Scientific (BSX) Halts Aortic Valve Systems, Boosting Com - GuruFocus
Boston Scientific (BSX) Halts Global Sales of ACURATE Valve Syst - GuruFocus
Boston Scientific at Bernstein Conference: Strategic Growth and Innovation - Investing.com
Abercrombie & Fitch, Boston Scientific, DoorDash - TradingView
Boston Scientific (BSX) Halts Global Sales of ACURATE Valve Systems | BSX Stock News - GuruFocus
Boston Scientific Ends ACURATE Valve Sales - Investing.com
Boston Scientific shares drop as valve systems are discontinued - Investing.com
Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & SuppliesDiversified Pack - Yahoo Finance
Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Boston Scientific (BSX) Price Target Raised by Citigroup | BSX S - GuruFocus
India Catheters Market Set to Witness Significant Growth - openPR.com
Was Jim Cramer Right About Boston Scientific Corporation (BSX)? - MSN
Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):